SPONSOR
The First Affiliated Hospital of Soochow University
Total Trials
6
Recruiting
6
Phases
Phase 1, Phase 2, Phase 1, EARLY_Phase 1
Conditions studied: Acute Myeloid Leukemia With T(8;21)(Q22;Q22)Acute Myeloid Leukemia With T(16;16)(P13;Q22)KIT Gene MutationAvapritinibPrimary Central Nervous System Lymphoma (PCNSL)CD30+ Peripheral T-cell LymphomaThrombotic MicroangiopathiesAtopic DermatitisB-Cell Acute Lymphoblastic Leukemia, Adult
NCT07028073 Phase 1, Phase 2
Recruiting
A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia
Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
NCT07074470
Recruiting
Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
Primary Central Nervous System Lymphoma (PCNSL)
NCT07074457
Recruiting
Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients
CD30+ Peripheral T-cell Lymphoma
NCT05634928
Recruiting
Construction of a Database for TMA
Thrombotic Microangiopathies
NCT07015762 Phase 1
Recruiting
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
Atopic Dermatitis
NCT06696833 EARLY_Phase 1
Recruiting
Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
B-Cell Acute Lymphoblastic Leukemia, Adult